Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies
出版年份 2019 全文链接
标题
Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies
作者
关键词
-
出版物
HEADACHE
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-11-11
DOI
10.1111/head.13691
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A new era for migraine: Pharmacokinetic and pharmacodynamic insights into monoclonal antibodies with a focus on galcanezumab, an anti-CGRP antibody
- (2019) William Kielbasa et al. CEPHALALGIA
- Pathophysiology, prevention, and treatment of medication overuse headache
- (2019) Hans-Christoph Diener et al. LANCET NEUROLOGY
- Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
- (2018) Vladimir Skljarevski et al. CEPHALALGIA
- Safety of galcanezumab in patients with episodic migraine: A randomized placebo-controlled dose-ranging Phase 2b study
- (2018) Tina Marie Myers Oakes et al. CEPHALALGIA
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Calcitonin-gene-related peptide pathway mAbs and migraine prevention
- (2018) Koen Paemeleire et al. CURRENT OPINION IN NEUROLOGY
- The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy
- (2018) Bianca Raffaelli et al. Neurotherapeutics
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention
- (2018) Vladimir Skljarevski et al. JAMA Neurology
- Pharmacologic Prevention of Migraine: A Narrative Review of the State of the Art in 2018
- (2018) Elizabeth Loder et al. HEADACHE
- Cycling Through Migraine Preventive Treatments: Implications for All-Cause Total Direct Costs and Disease-Specific Costs
- (2018) Janet H. Ford et al. Journal of Managed Care & Specialty Pharmacy
- The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
- (2018) HEADACHE
- Galcanezumab in chronic migraine
- (2018) Holland C. Detke et al. NEUROLOGY
- Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
- (2016) Zsolt Hepp et al. CEPHALALGIA
- A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability
- (2016) Richard B. Lipton et al. HEADACHE
- Systematic Review of Migraine Prophylaxis Adherence and Persistence
- (2016) Zsolt Hepp et al. JOURNAL OF MANAGED CARE PHARMACY
- Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention
- (2015) Richard B. Lipton et al. HEADACHE
- Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
- (2014) David W Dodick et al. LANCET NEUROLOGY
- The International Classification of Headache Disorders, 3rd edition (beta version)
- (2013) CEPHALALGIA
- Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)
- (2013) Andrew M. Blumenfeld et al. HEADACHE
- Rates and reasons for discontinuation of triptans and opioids in episodic migraine: Results from the American Migraine Prevalence and Prevention (AMPP) study
- (2013) Starr Holland et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators
- (2012) et al. CEPHALALGIA
- Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Table 1
- (2012) S.D. Silberstein et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search